Press Release – New York, NY – February 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.
The offering consisted of an aggregate of 1,889,000 units, with each unit consisting of one ADS and a warrant to purchase one ADS as well as 2,444,800 pre-funded units consisting of one pre-funded warrant and one warrant for aggregate proceeds of $6.5 million. The effective price of each unit was $1.50. Cellect has developed a breakthrough technology for the selection of stem cells from tissue that aims to improve a variety of stem cell based therapies. The Sichenzia Ross Ference team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeff Cahlon and associate Grant Levine.
[starbox id=1]